Engrailed 2 triggers the activation of multiple phosphorylation-induced signaling pathways in both

Yong Cao1, Jie Jiang2, Xueqin Song1

  • 1Experimental Medicine Center, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China; Luzhou Key Laboratory of Molecular Cancer, Luzhou, 646000, Sichuan, China.

Insights

Engrailed 2 (EN2) protein, beyond its transcription factor role, activates cancer signaling pathways. Blocking these pathways, including NF-κB and AKT, shows therapeutic promise for esophageal squamous cell carcinoma (ESCC).

Area of Science:

  • Molecular biology
  • Cancer research
  • Signal transduction

Background:

  • Homeodomain (HD)-containing proteins, like Engrailed 2 (EN2), are known transcription factors.
  • EN2 is highly expressed in various cancers, but its precise biological functions remain unclear.
  • Understanding EN2's mechanisms is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the transcription-independent functions of Engrailed 2 (EN2).
  • To identify signaling pathways regulated by EN2.
  • To explore therapeutic strategies targeting EN2 in cancer, specifically esophageal squamous cell carcinoma (ESCC).

Main Methods:

  • Phosphoproteomic analysis to identify altered protein phosphorylation sites upon EN2 expression.
  • Immunoprecipitation-mass spectrometry (IP-MS) to detect protein interactions.
  • Validation of EN2 interaction with PP2A-B55α complex and assessment of its phosphatase activity.
  • Pharmacological inhibition of EN2-activated NF-κB and AKT signaling pathways.

Main Results:

  • EN2 exhibits transcription-independent functions, activating multiple signaling pathways via phosphorylation cascades.
  • EN2 interacts with numerous proteins involved in phosphorylation signaling, including B55α, suppressing PP2A-B55α phosphatase activity.
  • Simultaneous inhibition of EN2-activated NF-κB and AKT pathways demonstrated synergistic effects.

Conclusions:

  • EN2 possesses significant transcription-independent roles in cancer progression.
  • EN2's interaction with PP2A-B55α and subsequent pathway activation contribute to malignancy.
  • Targeting EN2-mediated signaling pathways offers a potential therapeutic strategy for ESCC.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
47.0K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.0K